Literature DB >> 18455681

Immune-mediated pathways in chronic inflammatory arthritis.

Claire L Gorman1, Andrew P Cope.   

Abstract

Rheumatoid arthritis (RA) is the prototype chronic inflammatory arthropathy; its precise aetiology is unknown. Over recent years, a number of crucial advances in our understanding of the disease have had a major impact on the treatment of patients with RA.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18455681     DOI： 10.1016/j.berh.2008.01.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN： 1521-6942            Impact factor:   4.098


  24 in total

1.  Microarray-based gene expression profiling reveals the mediators and pathways involved in the anti-arthritic activity of Celastrus-derived Celastrol.

Authors:  Hua Yu; Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Int Immunopharmacol       Date:  2012-06-02       Impact factor: 4.932

2.  Alternative for anti-TNF antibodies for arthritis treatment.

Authors:  Joseph Paquet; Christel Henrionnet; Astrid Pinzano; Jean-Baptiste Vincourt; Pierre Gillet; Patrick Netter; Isabelle Chary-Valckenaere; Damien Loeuille; Jacques Pourel; Laurent Grossin
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

3.  Xanthones from Securidaca inappendiculata exert significant therapeutic efficacy on adjuvant-induced arthritis in mice.

Authors:  Jian Zuo; Yan Xia; Xiang Li; Jian-Wei Chen
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

4.  Dampened ERK signaling in hematopoietic progenitor cells in rheumatoid arthritis.

Authors:  Inés Colmegna; Sergey Pryshchep; Hisashi Oishi; Jörg J Goronzy; Cornelia M Weyand
Journal:  Clin Immunol       Date:  2012-01-28       Impact factor: 3.969

5.  Tinospora cordifolia inhibits autoimmune arthritis by regulating key immune mediators of inflammation and bone damage.

Authors:  K M Sannegowda; S H Venkatesha; K D Moudgil
Journal:  Int J Immunopathol Pharmacol       Date:  2015-10-14       Impact factor: 3.219

6.  Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis.

Authors:  Ying-Hua Yang; Rajesh Rajaiah; Erkki Ruoslahti; Kamal D Moudgil
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

7.  Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk.

Authors:  Siddaraju M Nanjundaiah; Shivaprasad H Venkatesha; Hua Yu; Li Tong; Joseph P Stains; Kamal D Moudgil
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

8.  Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses.

Authors:  Shivaprasad H Venkatesha; Hua Yu; Rajesh Rajaiah; Li Tong; Kamal D Moudgil
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

9.  Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis.

Authors:  S M Nanjundaiah; J P Stains; K D Moudgil
Journal:  Int J Immunopathol Pharmacol       Date:  2013 Jan-Mar       Impact factor: 3.219

10.  Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8).

Authors:  M D Zack; M A Melton; J L Stock; C E Storer; R A Barve; J C Minnerly; D J Weiss; J A Stejskal; M D Tortorella; J R Turk; K M Shevlin; A-M Malfait
Journal:  Clin Exp Immunol       Date:  2009-08-06       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.